Business
GREY WOLF ANIMAL HEALTH REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS
Grey Wolf Animal Health Corp. (TSXV: WOLF) ("Grey Wolf" or the "Company"), a Canadian diversified health company, today announced financial results for the three months ended March 31, 2026.
About this update from Grey Wolf Animal Health Corp
[{"type":"text","content":"TORONTO, May 21, 2026 /CNW/ - Grey Wolf Animal Health Corp. (TSXV: WOLF) ("Grey Wolf" or the "Company"), a Canadian diversified health company, today announced financial results for the three months ended March 31, 2026.","length":240,"tagName":"p"},{"type":"image","alt":"Grey Wolf Animal Health Corp. Logo (CNW Group/Grey Wolf Animal Health Corp.)","displaySize":"","headline":null,"caption":"Grey Wolf Animal Health Corp. Logo (CNW Group/Grey Wolf Animal Health Corp.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":256,"height":256,"url":"https://media.zenfs.com/en/cnwgroup.com/6dc02dd43d2a47d6c877bb70988aabdd"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/G0dy_VtCQHG8A0q9X2rpvg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTQyMA--/https://media.zenfs.com/en/cnwgroup.com/6dc02dd43d2a47d6c877bb70988aabdd","width":256,"height":256},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/G0dy_VtCQHG8A0q9X2rpvg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTQyMA--/https://media.zenfs.com/en/cnwgroup.com/6dc02dd43d2a47d6c877bb70988aabdd","width":256,"height":256}},"href":"https://mma.prnewswire.com/media/2985683/Grey_Wolf_Animal_Health_Corp__GREY_WOLF_ANIMAL_HEALTH_REPORTS_FI.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Highlights","length":10,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Revenue for the quarter increased year over year by 10.5% to $8.8 million.","length":74,"tagName":"p"}]},{"val":[{"type":"text","content":"Gross profit increased year over year by 13.5% to $4.7 million for the quarter.","length":79,"tagName":"p"}]},{"val":[{"type":"text","content":"Adjusted EBITDA1 increased year over year by 16.6% to $1.5 million for the quarter.","length":83,"tagName":"p"}]},{"val":[{"type":"text","content":"Introducing a 5-year financial target to organically double Adjusted EBITDA1 by the end of 2030.","length":96,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":332,"olType":false},{"type":"text","content":""We posted a solid first quarter for both revenue and Adjusted EBITDA," said Angela Cechetto, Chief Executive Officer. "Our Pharmacy business grew organically by 8.8% to $5.6 million due to an increase in sales of compounded products. Meanwhile, our Animal Health revenue grew by 13.8% to $3.1 million year-over-year result...